hRBP-virion · Comprehensive identification of host factors involved in the early steps of HIV infection.
Horizon 2020 — Marie Skłodowska-Curie Actions
- Duration
- 2017-05-03 → 2019-05-02
- EU contribution
- €195,455
- Participants
- 1
- Scheme
- MSCA-IF
Lines connect the coordinator with its partners.
Results in brief
Comprehensive identification of host factors involved in the early steps of HIV infection.
RNA viruses represent a major health threat to humans and other living organisms. In particular, human immunodeficiency virus (HIV) is the second cause of death worldwide due to a single pathogen and currently 37 million people is infected. The high mutation rate of viral RNA genomes usually lead to rapid evolution, making difficult the development of effective antiviral treatments, vaccines and a final cure. Understanding how viruses interact with the host cell remain essential for the eventual discovery of complementary therapeutic strategies. RNA has a central role in virus biology, yet viral genomes encode only a few proteins able to interact with RNA. Hence, viruses exploit host RNA-binding proteins (RBPs) to accomplish their biological cycle. Although poorly explored until now, many of these RBPs are promising targets for host-based antiviral intervention. The participation of cellular RBPs in virus infection has been investigated for decades, mostly on a case-by-case basis. However, the universe of proteins enabled with RNA-binding activity has dramatically expanded in recent years. For these reasons, the complement of host RBPs involved in virus infection has remained largely unknown. To fill this gap, we aimed at (i) curating all the human RBPs that had previous links to infection using a tailored computational pipeline; and (ii) creating a novel system-wide method to study experimentally changes in the cellular RNA-binding proteome in response to infection, using a tractable and safe RNA virus model, called sindbis. Once established in sindbis virus, our methods were applied to study HIV infection. After HIV entry into the host cell, the RNA genome is reversed transcribed into DNA and imported into the nucleus to be integrated into the chromosome. Recent evidence showed that reverse transcription occurs inside the viral capsid shell. This implies that all proteins required for early viral RNA metabolism must be already contained within the capsid and are taken up in the producer cell (summary figure A). The main goal of this project was to define the scope of host RBPs packed within HIV capsids and their biological significance on the early steps of infection. Two major conclusions arise from this project: (i) hundreds of cellular RBPs are involved in virus infection and affect the infection outcome; and (ii) specific host RBPs are incorporated into HIV capsids and have essential roles in virus spread. Cellular RBPs are thus master regulators of viral replication and represent promising targets for host-based antiviral therapies.
Data: CORDIS, © European Union
Project objective
35 million people are currently infected with Human immunodeficiency virus (HIV), causative agent of AIDS. While cocktails of anti-retrovirals can reduce viral loading to undetectable levels, drug resistance can emerge due to the high-mutation rate of the virus. Moreover, no cure is yet achieved. Therefore, it is crucial to explore complementary therapeutic strategies, a challenge that H2020 prioritizes in health. The strict dependency of HIV on host RNA-binding proteins (RBPs) represents a potential step for intervention through host-based therapies, which can be more refractory to the evolution of resistance. In some sporadic cases, host RBPs have been shown to be incorporated into virions and impact downstream early steps of infection. However, no global and systematic studies aimed to determine the scope and biological significance of host RBPs selectively packed with the HIV RNA within the virions have been reported so far. The main goal of this action, referred to as hRBP-virion, is to address this important biological question by developing an unprecedented multidisciplinary approach that combines molecular biology and virology methods with next generation proteomics and data analysis. Hence, this pioneer approach will open new avenues of research in the field of viruses that have major health and socioeconomic impact and will enhance world-class basic and applied European innovation. The hRBP-virion project requires an exclusive mix of competences. I will bring research experience in RNA and molecular virology. My supervisor will train me in cutting-edge, system-wide proteomic methods. The host institution will provide state-of-the-art facilities and pooled expertise in a broad range of disciplines. Together these will create an excellent and unique cross-disciplinary atmosphere that will ensure the successful outcome of hRBP-virion and the appropriate transfer of knowledge among the participants.
Original text from CORDIS.
Participants
- THE CHANCELLOR, MASTERS AND SCHOLARS OF THE UNIVERSITY OF OXFORD · OxfordCoordinatorUnited Kingdom
Links
Data: CORDIS, © European Union
